AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

KE · NASDAQ · Electrical Equipment & Parts

Kimball Electronics

Builds electronics and medical devices for automotive, medical, and industrial customers.

$23.46

After-hours close+0.04 (+0.17%)

At close$23.42(−2.78%)

Something off on this page? Send us feedback.

Profile

Kimball Electronics, Inc.KEIndustrials

Provides electronics manufacturing, medical CMO/CDMO, and engineering support for customers in automotive, medical, and industrial markets. Its model depends on contract programs, global facilities, long-term customer relationships, and a strategic shift toward medical manufacturing.

Provides electronics manufacturing services, medical CMO/CDMO services, and engineering and design support for customers that outsource complex product builds. Work spans PCBAs, final assembly, supply-chain support, reliability testing, medical disposables, drug-delivery solutions, clean-room assembly, and precision molded plastics.

Operations are based in Jasper, Indiana, with manufacturing and business units across the United States, China, Mexico, Poland, Romania, and Thailand. The Helvoet acquisition adds European and Indian medical CDMO capabilities tied to microfluidics, diagnostics, and drug delivery.

Recent portfolio actions narrow the business toward core EMS and medical manufacturing after the AT&M divestiture. The issuer remains Kimball Electronics while the Kimball Solutions parent-name change awaits share-owner approval.

Company facts

CEORichard D. Phillips

ListedNov 3, 2014

ExchangeNASDAQ

HeadquartersJasper, IN

CountryUnited States

Employees5,700

CIK0001606757

ISINUS49428J1097

Key statistics

Market cap$564.2M

EPS (ttm)$1.13

P/E (ttm)20.76

ROE4.8%

P/B0.9755

P/S0.3942

Dividend yield—

Beta1.91vs XLI 0.41

Year to date −18.7% · Average volume (30d) 210.5K

Analysts

Price target, next 12 months$26.00+10.8%Median of 5 analysts · vs the Aug 28 close

ConsensusBuy3 of 5 analysts rate it buy or better

Ratings

Strong buyBuyHoldSellStrong sell

Target range

Last close $23.46

High$32.00+36.4%

Median$26.00+10.8%

Low$20.00−14.7%

12 months agoNowIn 12 months

Latest analyst notes

Date	Firm	Action	Rating	Prior target	Target
Jul 2, 2026	KeyBanc	Initiate	Sector Weight
Nov 7, 2025	Lake Street	Target		$23	$32

Earnings

EPS

Estimate$0.34

ReportedDue Nov 4, 2026

Revenue

Estimate$385.7M

ReportedDue Nov 4, 2026

History

Report date	EPS est	EPS	Surprise	Revenue est	Revenue	Surprise	Next session
Aug 12, 2026Q4 FY26	$0.39	−$0.01	−102.6%	$373.6M	$371.6M	−0.6%	+3.33%
May 5, 2026Q3 FY26	$0.38	$0.33	−13.2%	$356.3M	$352.9M	−0.9%	−7.33%
Feb 4, 2026Q2 FY26	$0.28	$0.28	0.0%	$339.3M	$341.3M	+0.6%	−23.34%
Nov 5, 2025Q1 FY26	$0.24	$0.49	+104.2%	$343.0M	$365.6M	+6.6%	−7.31%

View details

Financial highlights

	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26
Revenue	$374.6M	$380.5M	$365.6M	$341.3M	$352.9M	$371.6M
Gross profit	$26.9M	$30.5M	$29.0M	$27.9M	$26.1M	$32.9M
Operating income	$11.7M	$16.5M	$15.9M	$13.0M	$11.1M	$29.1M
Net income	$3.8M	$6.6M	$10.1M	$3.6M	$5.7M	$8.5M
Diluted EPS	$0.15	$0.26	$0.40	$0.15	$0.23	$0.35
Gross margin	7.2%	8.0%	7.9%	8.2%	7.4%	8.9%
Operating margin	3.1%	4.3%	4.3%	3.8%	3.1%	7.8%

Fiscal years (4-quarter sums)FY22 $1.35B · FY23 $1.82B · FY24 $1.71B · FY25 $1.49B · FY26 $1.43B

Revenue by product · Q4 FY26

Automotive$169.7M · 46%

Medical$108.8M · 29%

Industrial$93.1M · 25%

Revenue by geography · FY26

Mexico$359.7M · 25%

United States$293.6M · 21%

Poland$288.7M · 20%

China$236.5M · 17%

Thailand$158.6M · 11%

Other Foreign$94.3M · 7%

Balance sheet, Jun 30, 2026Cash & short-term investments $88.9M · Total debt $116.2M · Total assets $1.09B · Shareholders' equity $585.1M

Dividends

No dividends on record.

Ownership

Institutions 88.28%21.23M sharesInsiders 2.25%540.4K sharesOther 9.47%2.28M shares

Shares outstanding 24.05M · Float 23.59M · 98.1% free float

Top shareholders13F · 13D/G · Form 4

Holder	Shares	% outstanding	Form	Filed
BlackRock, Inc.	2.44M	10.15%	13F	Aug 7, 2026
Dimensional Fund Advisors LP	1.66M	6.89%	13F	Aug 11, 2026
American Century Investment Management, Inc.	1.31M	5.40%	13G	Aug 14, 2026
Bank of America Corp /DE/	1.19M	4.95%	13F	Aug 14, 2026
Vanguard Capital Management LLC	1.07M	4.44%	13F	Aug 13, 2026

Insider tradesForm 4

No open-market trades in the last 12 months.